01.11.21 -- New Year, New Podcast Episodes: Clinical Trials During A Pandemic; Gene Therapies At Scale

Check out the latest from Business of Biotech, Bioprocess with the Bozenhardts, and Life Science Connect. As a member of the Life Science Connect community you have access to content beyond our weekly newsletters, including our podcast series. Don’t forget to subscribe so that you never miss an episode!

From patient recruitment to data collection, clinical trials execution became considerably more challenging in 2020. On this episode of Business of Biotech, AGTC CEO Sue Washer gives us a behind-the-scenes look at the creative measures her company took to serve a geographically dispersed clinical patient population and ensure her company met clinical milestones.

Listen in as AVROBIO president and CEO Geoff MacKay tells Business of Biotech about the technology his company is using to drive at-scale gene therapy production for lysosomal disorders, replete with the story of how the company overcame a major manufacturing investment that didn't quite work as planned.

Herman and Erich Bozenhardt have a combined 55 years of bioprocess facilities design and equipment experience, and they’re here to share it all in our fresh Bioprocess with the Bozenhardts podcast series.

2020 seems to be the year of the evolution of the atypical, newfangled CDMO. Outsourced Pharma editor Louis Garguilo talks about this trend and what makes these new models all the rage.